ABC | Volume 110, Nº5, Maio 2018

Artigo Original Almeida et al MTWA e arritmias malignas na doença de Chagas Arq Bras Cardiol. 2018; 110(5):412-417 15. ChowT,KereiakesDJ,BartoneC,BoothT,SchlossEJ,WallerT,etal.Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol. 2007;49(1):50-8. doi: 10.1016/j.jacc.2006.06.079. 16. Tanno K, Ryu S, Watanabe N, Minoura Y, Kawamura M, Asano T, et al. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias a prospective study using atrial pacing. Circulation. 2004;109(15):1854-8. doi: 10.1161/01.CIR.0000124717.77777.EC. 17. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol. 2005;46(1):75-82. doi: 10.1016/j.jacc.2005.03.059. 18. Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al; SociedadeBrasileiradeCardiologia.[ILatinAmericanguidelinesforthediagnosis and treatment of Chagas cardiomyopathy]. Arq Bras Cardiol. 2011;97(2 Suppl 3):1-48.doi :http://dx.doi.org/10.1590/S0066-782X2011000600002. 19. Brasil.MinistériodaSaúde:SecretariadeAtençãoàSaúde.Portarianº.152,de8 demarçode2007.DefineatravésdaPolíticaNacionaldeAtençãoCardiovascular deAltaComplexidade,oImplantedeMarcapassosdeAltoCusto.DiárioOficial daUnião.PoderExecutivo.Brasilia(DF);09demarçode2007. 20. Brasil.Ministério da Saúde: Secretaria de Atenção à Saúde. Portaria nº. 1, de 2 de Janeiro de 2014. Atualiza o protocolo do uso do cardioversor desfibrilador implantável a ser adotado nos estabelecimentos de saúde credenciados no Sus. DiárioOficial da União.Poder Executivo. Brasilia(DF); 03 de janeiro de 2014. Seção 1,p.29-32. 21. FletcherGF,AdesPA,KligfieldP,ArenaR,BaladyGJ,BittnerVA,etal;American HeartAssociationExercise,CardiacRehabilitation,andPreventionCommittee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity andMetabolism,CouncilonCardiovascularandStrokeNursing,andCouncil on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873-934. doi: 10.1161/CIR.0b013e31829b5b44. 22. MerchantFM,Salerno-Uriarte JA,CaravatiF,FalconeS,MolonG,Marangoni D, et al. Prospective use of microvolt T-wave alternans testing to guide primary prevention ICD therapy. Circ J. 2015;79(9):1912-9. doi: 10.1253/ circj.CJ-15-0253. 23. Kraaier K, Olimulder MA, vanDessel PF, Wilde AA, ScholtenMF. Prognostic value of microvolt T-wave alternans in a real-world ICDpopulation. Twente ICDCohort Studie (TICS). NethHeart J. 2014;22(10):440-5. doi: 10.1007/ s12471-014-0583-3. 24. Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, et al. “Indeterminate” microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006;48(7):1399-404. doi: 10.1016/j.jacc.2006.06.044. 25. Chow S, Shao J, Wang H. Sample Size Calculations in Clinical Research. 2nd ed. Boca Raton (FL):Chapman & Hall/CRC;2008 (Biostatistics Series) ISBN:-58488-982-9 26. Barbosa MP, da Costa Rocha MO, Neto ES, Brandão FV, Lombardi F, Ribeiro AL. Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators. Int J Cardiol. 2016 Nov 1;222:80-5. doi: 10.1016/j. ijcard.2016.07.148. 27. RCore Team. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing: Vienna, Austria; 2016. [Cited in 2017 Mar 30]. Available from: https://www.R-project.org/ 28. Ribeiro AL, Rocha MO, Terranova P, Cesarano M, Nunes MD, Lombardi F. T-wave amplitude variability and the risk of death in Chagas disease. J Cardiovasc Electrophysiol. 2011;22(7):799-805. doi: 10.1111/j.1540- 8167.2010.02000.x. 29. Raadschilders L, BarbosaMP, CarmoAA, Nouwen JL, RochaMO, RibeiroAL. Microvolt T-wave alternans in Chagas disease. Int J Cardiol. 2015;187:7-8. doi: 10.1016/j.ijcard.2015.03.253. 30. Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL; Council on Chagas Disease of the Interamerican Society of Cardiology. Chagas Disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62(9):767-76. doi: 10.1016/j.jacc.2013.05.046. 31. WilsonLD,RosenbaumDS.Mechanismsofarrythmogeniccardiacalternans. Europace. 2007 Nov;9 Suppl 6:vi77-82. doi: 10.1093/europace/eum210. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 417